Verve Therapeutics Common Stock

Verve Therapeutics (VERV) currently reports a common stock of $89K as of March 2025. That compares with $84K in the prior-year period — up 6.0% year over year. Use the charts on this page to explore Verve Therapeutics's common stock history and peer comparisons.

Verve Therapeutics's common stock increased from $84K to $89K — a 6.0% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Verve Therapeutics reported $89K in common stock as of March 2025. That compares with $84K in the prior-year period — up 6.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $89K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Verve Therapeutics, and consider following VERV for alerts when major investors trade the stock.

Verve Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $89K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VERV with unrelated industries.